As we are interested in identifying genes that may regulate tumor cells response to anti–PD-1 therapy, sgRNA library composition of the tumors was first compared to that of the original cell pools and then plotted against each other (Fig. 1B). This evidence concerns the gene PDCD1 and neoplasm.